Previous Article | Next Article ![]()
Infection and Immunity, April 2000, p. 2363-2365, Vol. 68, No. 4
Division of Infectious Diseases, University
of Colorado Health Science Center, Denver,
Colorado,1 and Departments of
Surgical Pathology,2
Surgery,3 and Medical
Microbiology and Immunology,4 University of
Wisconsin Medical School, Madison, Wisconsin
Received 6 July 1999/Returned for modification 23 August
1999/Accepted 3 January 2000
Although highly susceptible to orogastric candidiasis, T-cell
receptor Several immunosuppressive and
immunodeficiency-related conditions predispose humans to candidiasis
(12, 13, 15). In general, animal and clinical studies
suggest that T cells are important for resistance to mucosal
candidiasis and to systemic candidiasis of endogenous origin. For
instance, CD4 deficiencies in humans and T-cell defects in animal
models, such as those found in SCID, athymic, major histocompatibility
complex class I knockout (KO) mice and TCR Between 10 and 30 days after colonization with C. albicans,
both TCR
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Disparate Requirement for T Cells in Resistance to
Mucosal and Acute Systemic Candidiasis
![]()
ABSTRACT
Top
Abstract
Text
References
- and
-chain knockout mice, deficient in 
and

T cells, respectively, were found to be resistant to
disseminated candidiasis of endogenous origin and to acute systemic
candidiasis (resulting from intravenous injection).
![]()
TEXT
Top
Abstract
Text
References

- or
CD4+-T-cell-depleted mice, have all been associated with
increased susceptibility to mucosal candidiasis (1, 3, 5, 6, 8,
11). Some of these T-cell deficiencies, however, have been
associated with hyperresistance to experimentally induced systemic
candidiasis (1, 6, 8, 14), thus suggesting that T cells
inhibit clearance and may even contribute to the pathology of acute
systemic candidiasis. To better understand the roles of different
T-cell subsets in resistance to orogastric and systemic candidiasis,
mice with genetically engineered deficiencies in 
or 
T
cells (i.e., T-cell receptor [TCR]
- and
-chain KO mice,
respectively) were used in this study. We now report that mice without

or 
T cells are susceptible to orogastric candidiasis;
however, neither T-cell subset appears to be required for murine
resistance to acute systemic candidiasis or to systemic candidiasis of
endogenous (alimentary tract) origin.
and
-chain KO mice (Jackson Laboratories, Bar Harbor, Maine)
and the corresponding C57BL/6 × L129 controls were derived into
the germfree state at the University of Wisconsin Gnotobiote Laboratory
in Madison (1), and their gnotobiotic and T-cell-deficient statuses were tested as previously described (10, 19).
Germfree mice were orally swabbed with a suspension of 108
Candida albicans CFU/ml. Colonization of the alimentary
tract by the fungus was confirmed 3 days later by culturing fecal
contents on Sabouraud dextrose agar. At several time points following
colonization with C. albicans, the mice were euthanized and
their orogastric tissues
i.e., tongue, hard palate, esophagus, and
stomach tissues
were fixed in 10% buffered formalin and stained with
hematoxylin-eosin and Gomori's methenamine silver for histologic
analysis (2). These mice were also tested for
extraintestinal dissemination of C. albicans by culturing
spleen, liver, kidney, and brain homogenates on Sabouraud dextrose
agar. The susceptibility of T-cell-deficient and control mice to
systemic candidiasis was assessed by determining the fungal burdens in
spleen, liver, kidney, and brain tissues of mice inoculated
intravenously with 104 CFU of C. albicans.
- and
-chain KO mice had similar grades of mucosal infection (histopathology scores of 2.5, as defined by the presence of
budding yeast cells and hyphal penetration) but different incidences (100 and 50%, respectively) of orogastric infection (Table
1; Fig. 1).
In contrast to beige-athymic mice, which are deficient in phagocytic
cells and thymus-educated T-cell and natural killer cell function
(5), adult TCR
-chain KO mice, deficient in 
T
cells, and TCR
-chain KO mice, deficient in 
T cells, did not
die when their gastrointestinal tracts were chronically colonized with
C. albicans (30-day study). However, chronic colonization proved lethal for infant TCR
-chain KO mice. Ten 3-week-old TCR
-chain KO mice, born to and raised by two different C. albicans-monoassociated TCR
-chain KO mothers, became emaciated
and died at about 21 days after birth. Their esophagi were occluded by
C. albicans and squamous debris (Fig.
2).
TABLE 1.
TCR
- and
-chain KO mice are susceptible to
orogastric candidiasis after oral colonization with a pure culture
of C. albicans

View larger version (116K):
[in a new window]
FIG. 1.
Grade 3 infection of stomach by C. albicans
in an 11-week-old TCR
-chain KO mouse that was colonized for 10 days. Arrows indicate hyphae. All adult mice used for this study were 8 to 15 weeks of age. Germfree mice were orally colonized by swabbing
their mouths with 108 CFU of C. albicans as
previously described (18). At least two or three
longitudinal sections of tissues were stained and examined for each
mouse. Gomori's methenamine silver stain; magnification, ×80.

View larger version (122K):
[in a new window]
FIG. 2.
Occlusion of esophagus by C. albicans in a
3-week-old TCR
-chain KO mouse that was colonized at birth.
Gomori's methenamine silver stain; magnification, ×80.
Unfortunately, TCR
-chain KO mice did not breed well under germfree
or C. albicans-monoassociated conditions, so the role of

T cells in conferring protection to young animals is unclear. Nevertheless, it is interesting that two pups that were born to a
C. albicans-colonized TCR
-chain KO mother survived to
adulthood and showed no indication of orogastric lesions when they were sacrificed at 5 months of age.
In summary, adult 
- or 
-T-cell-deficient mice can survive
oral colonization with C. albicans; however, 
T cells
appear to be essential for protecting infant mice from the lethal
effects of a natural C. albicans colonization obtained by
contact with colonized mothers. Immunocompetent C57BL/6 × L129
controls showed no histologic evidence of orogastric candidiasis at the
time points (30 days or at birth) examined in this study. In accordance
with other studies (1-3, 5, 10-12, 14), the hyphae and
budding yeast cells present on mucosal surfaces of either TCR-KO strain of mouse colonized by C. albicans suggest that both 
and 
T cells participate in host resistance to mucosal candidiasis.
No disseminated candidiasis was detected in the spleens, livers,
kidneys, or brains of orally colonized immunocompetent or TCR-deficient
mice, regardless of the grade of mucosal infection sustained. The
latter data suggest that 
and 
T cells are not required for
protection of mice from systemic candidiasis of endogenous origin.
Paradoxically, the absence of CD8+ T cells or the lack
of an major histocompatibility complex class I classical or
nonclassical antigen-presenting pathway does lead to dissemination from
the mucosal surface to internal organs (3). Other immune
system defects associated with dissemination include concomitant
defects in phagocytes, natural killer cells, and CD4+ T
cells (i.e., bg/bg nu/nu mice [5]),
depletion of phagocytes in SCID mice (9), and genetic
abrogation of intracellular adhesion molecules which impair leukocyte
infiltration and activation (7). T- and B-cell-deficient
SCID mice with intact phagocytic function, although somewhat more
susceptible to gastric candidiasis than immunocompetent controls,
manifest resistance to disseminated candidiasis of endogenous origin
and to acute systemic candidiasis (2, 14). Perhaps the
disruption of the balance between T-cell subsets and phagocytic cell
deficiencies lead to diminished resistance to disseminated candidiasis
of endogenous origin.
Both TCR
- and
-chain KO mice eliminated C. albicans
from the spleen, liver, kidney, and brain by day 14 after intravenous challenge with 104 C. albicans CFU, which is in
sharp contrast with the 105 C. albicans CFU per
g of dry tissue we observed in intravenously challenged immunocompetent
controls (Fig. 3). The latter results suggest that resistance to acute systemic candidiasis is independent of

and 
T cells. Our data are consistent with previous
studies with patients and animal models which have noted that defects in innate, T-cell-independent immune responses, such as those associated with chronic granulomatous disease or myeloperoxidase deficiencies, predispose humans to systemic, but not mucosal, candidiasis (13, 15, 16). Also, in view of the resistance of
T-cell-deficient mice (references 3, 6, and 8 and this study) and in light of the increased susceptibility of
B-cell-deficient (18), phagocyte-deficient (4, 5,
9), and thymically reconstituted nude mice (17) to
systemic candidiasis, it is likely that B cells and/or phagocytes,
rather than 
and 
T cells, play an important and dominant
role in host resistance to acute systemic candidiasis. In fact, our
data suggest that T cells may contribute to immunopathology in this
particular presentation of the disease, because T-cell-competent mice
were more susceptible to renal candidiasis than T-cell-deficient (TCR
- or
-chain KO) mice (Fig. 3).
|
Our experiments with these murine models support clinical observations that T-cell deficiencies are associated with susceptibility to orogastric candidiasis. Novel to this study was the observation that both T-cell subsets independently participated in host immunity to orogastric candidiasis while their presence during acute systemic challenge exacerbated murine susceptibility to renal candidiasis.
| |
ACKNOWLEDGMENTS |
|---|
We thank Donna Brackett for secretarial preparation of the
manuscript and R. D. Wagner for help in collecting some of the tissues for histological analysis. We also thank JoAnne Croft and the
staff of the Gnotobiote Laboratory at the University of Wisconsin
Madison for maintaining the animals used in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Wisconsin Medical School, Departments of Surgery and Medical Microbiology/Immunology, 1300 University Ave., 4638 MSC, Madison, WI 53706-1532. Phone: (608) 263-1670. Fax: (608) 265-3461. E-mail: balish{at}surgery.wisc.edu.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Balish, E.,
M. J. Balish,
C. A. Salkowski,
K. W. Lee, and K. F. Bartizal.
1984.
Colonization of congenitally athymic, gnotobiotic mice by Candida albicans.
Appl. Environ. Microbiol.
47:647-652 |
| 2. | Balish, E., J. Jensen, T. Warner, J. Brekke, and H. Leonard. 1993. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 31:143-154[Medline]. |
| 3. |
Balish, E.,
F. A. Vazquez-Torres,
J. Jones-Carson,
R. D. Wagner, and T. Warner.
1996.
Importance of 2-microglobulin in murine resistance to mucosal and systemic candidiasis.
Infect. Immun.
64:5092-5097[Abstract].
|
| 4. |
Cantorna, M. T., and E. Balish.
1990.
Mucosal and systemic candidiasis in congenitally immunodeficient mice.
Infect. Immun.
58:1093-1100 |
| 5. |
Cantorna, M. T., and E. Balish.
1991.
Role of CD4+ lymphocytes in resistance to mucosal candidiasis.
Infect. Immun.
59:2447-2455 |
| 6. | Cutler, J. E. 1976. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. 19:121-124[Medline]. |
| 7. | Davis, S. L., E. P. Hawkins, E. O. Mason, Jr., C. W. Smith, and S. L. Kaplan. 1996. Host defenses against disseminated candidiasis are impaired in intercellular adhesion molecule 1-deficient mice. J. Infect. Dis. 174:435-439[Medline]. |
| 8. | Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912-919[Medline]. |
| 9. | Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in murine resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170:900-905[Medline]. |
| 10. | Jones-Carson, J., F. A. Vazquez-Torres, and E. Balish. 1997. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans. J. Immunol. 158:4328-4335[Abstract]. |
| 11. |
Jones-Carson, J.,
A. Vazquez-Torres,
H. C. van der Heyde,
T. Warner,
R. D. Wagner, and E. Balish.
1995.
![]() T cell-induced nitric oxide production enhances resistance to mucosal candidiasis.
Nat. Med.
1:552-557[CrossRef][Medline].
|
| 12. | Klein, R. S., C. A. Harris, C. B. Small, B. Moll, M. Lesser, and G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358[Abstract]. |
| 13. |
Lehrer, R. I.
1970.
Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils.
Infect. Immun.
2:42-47 |
| 14. |
Narayanan, R.,
W. A. Joyce, and R. A. Greenfield.
1991.
Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.
Infect. Immun.
59:2116-2119 |
| 15. | Oh, M. K., C. E. Rodey, R. A. Good, R. A. Chilgren, and P. G. Quie. 1969. Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J. Pediatr. 75:300-303[CrossRef][Medline]. |
| 16. | Parry, M. F., R. K. Root, J. A. Metcalf, K. K. Delaney, L. S. Kaplow, and W. J. Richar. 1981. Myeloperoxidase deficiency: prevalence and clinical significance. Ann. Intern. Med. 95:293-301. |
| 17. | Rogers, T. J., E. Balish, and D. D. Manning. 1976. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel. Soc. 29:291-298. |
| 18. | Wagner, R. D., A. Vazquez-Torres, J. Jones-Carson, T. Warner, and E. Balish. 1996. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J. Infect. Dis. 174:589-597[Medline]. |
| 19. | Yale, C. E., and E. Balish. 1976. Blood and serum chemistry values of gnotobiotic beagles. Lab. Anim. Sci. 26:633-639[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|